• 2025
  Taieb F, Baidaliuk A, Durand A, Prot M, Jidar K, Hochedez P, Consigny PH, Itani O, Simon-Loriere E, Phylogenetic analysis of chikungunya virus in travellers returning from La Reunion Island., J Travel Med 2025 Aug; (): .
• 2025
  Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA, Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study., Lancet Infect Dis 2025 Mar; 25(3): 301-311.
• 2025
  Casadémont I, Ayala-Suárez R, Modhiran N, Tawfik A, Prot M, Paul R, Simon-Lorière E, Díez-Fuertes F, Ubol S, Alcamí J, Sakuntabhai A, miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., Med Microbiol Immunol 2025 Feb; 214(1): 13.
• 2025
  Xin GY, Wang DX, Zhang X, Cen QQ, Peng MW, Liao YQ, Wang J, Le SJ, Cheng JX, Wu WC, Hou X#, Luo GY, Gou QY, Kong JB, Pan Z, Li DQ, Gan SP, Chen A, Zhao HL, Shi PB, Ren ZR, Zhao WQ, Liu JJ, Jia PH, Sun CY, Lin WQ, Wu J, Kuang GP, Chen JD, Li JH, Holmes EC, Deng ZQ, Shi M. , Infectome analysis of small mammals in Southern China reveals ecological associations and emerging threats from diverse pathogens, bioRxiv.
• 2025
  Hou X#, Wang J, Wang DX, Chen Y, Li XX, Wu WC, Le SJ, Mei SQ, Liu HL, Feng Y, Yang LF, Shi PB, Ren ZR, Yang L, He HJ, Song WJ, Chen J, Zhu MM, Jiang ZW, Li XM, Guo D, Holmes EC, Deng ZQ, Shi M., Comprehensive infectome analysis reveals diverse infectious agents with zoonotic potential in wildlife, bioRxiv.
• 2025
  Vernuccio R, Martínez León A, Poojari CS, Buchrieser J, Selverian CN, Jaleta Y, Meola A, Guivel-Benhassine F, Porrot F, Haouz A, Chevreuil M, Raynal B, Mercer J, Simon-Loriere E, Chandran K, Schwartz O, Hub JS, Guardado-Calvo P, Structural insights into tecovirimat antiviral activity and poxvirus resistance., Nat Microbiol 2025 Mar; 10(3): 734-748.
• 2024
  Planchais C, Fernández I, Chalopin B, Bruel T, Rosenbaum P, Beretta M, Dimitrov JD, Conquet L, Donati F, Prot M, Porrot F, Planas D, Staropoli I, Guivel-Benhassine F, Baquero E, van der Werf S, Haouz A, Simon-Lorière E, Montagutelli X, Maillère B, Rey FA, Guardado-Calvo P, Nozach H, Schwartz O, Mouquet H, Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
• 2024
  Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, Dehan O, Avon L, Bolland WH, Hubert M, Buchrieser J, Vanhoucke T, Rosenbaum P, Veyer D, Péré H, Lina B, Trouillet-Assant S, Hocqueloux L, Prazuck T, Simon-Loriere E, Schwartz O, Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion., Nat Commun 2024 Mar; 15(1): 2254.
• 2024
  Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, Prot M, Guivel-Benhassine F, Lemoine F, Enouf V, Simon-Loriere E, Mouquet H, Rameix-Welti MA, Schwartz O, Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies., Pathog Immun 2024 ; 10(1): 1-11.
• 2023
  Bolland W, Michel V, Planas D, Hubert M, Staropoli I, Guivel-Benhassine F, Porrot F, N'Debi M, Rodriguez C, Fourati S, Prot M, Planchais C, Hocqueloux L, Simon-Lorière E, Mouquet H, Prazuck T, Pawlotsky J-M, Bruel T, Schwartz O, Buchrieser J, High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1., J Virol 2023 Dec; (): e0135123.
• 2023
  Gámbaro F, Pérez AB, Prot M, Agüera E, Baidaliuk A, Sánchez-Seco MP, Martínez-Martínez L, Vázquez A, Fernandez-Garcia MD, Simon-Loriere E, Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019., Euro Surveill 2023 Nov; 28(45): .
• 2023
  Saunders N, Fernandez I, Planchais C, Michel V, Rajah MM, Baquero Salazar E, Postal J, Porrot F, Guivel-Benhassine F, Blanc C, Chauveau-Le Friec G, Martin A, Grzelak L, Oktavia RM, Meola A, Ahouzi O, Hoover-Watson H, Prot M, Delaune D, Cornelissen M, Deijs M, Meriaux V, Mouquet H, Simon-Lorière E, van der Hoek L, Lafaye P, Rey F, Buchrieser J, Schwartz O, TMPRSS2 is a functional receptor for human coronavirus HKU1., Nature 2023 Oct; (): .
• 2023
  Hugo Caro, Sulyvan Dollin, Anne Biton, Bryan Brancotte, Dimitri Desvillechabrol, Yoann Dufresne, Blaise Li, Etienne Kornobis, Frédéric Lemoine, Nicolas Maillet, Amandine Perrin, Nicolas Traut, Bertrand Néron, Thomas Cokelaer, BioConvert: a comprehensive format converter for life sciences, NAR Genomics and Bioinformatics, 2023, 5 (3), ⟨10.1093/nargab/lqad074⟩.
• 2023
  Zaharias P, Lemoine F, Gascuel O, Robustness of Felsenstein’s Versus Transfer Bootstrap Supports With Respect to Taxon Sampling., Syst Biol 2023 Aug; (): .
• 2023
  de Melo GD, Perraud V, Alvarez F, Vieites-Prado A, Kim S, Kergoat L, Coleon A, Trüeb BS, Tichit M, Piazza A, Thierry A, Hardy D, Wolff N, Munier S, Koszul R, Simon-Lorière E, Thiel V, Lecuit M, Lledo PM, Renier N, Larrous F, Bourhy H, Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants., Nat Commun 2023 Jul; 14(1): 4485.
• 2023
  Cokelaer T, Cohen-Boulakia S, Lemoine F, Reprohackathons: promoting reproducibility in bioinformatics through training., Bioinformatics 2023 Jun; 39(39 Suppl 1): i11-i20.
• 2023
  Suspène R, Raymond KA, Boutin L, Guillier S, Lemoine F, Ferraris O, Tournier JN, Iseni F, Simon-Lorière E, Vartanian JP, APOBEC3F is a mutational driver of the human Monkeypox virus identified in the 2022 outbreak., J Infect Dis 2023 May; (): .
• 2023
  Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, Lemoine F, Agou F, Simon-Lorière E, van der Werf S, de Lamballerie X, Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
• 2023
  Temmam S, Montagutelli X, Herate C, Donati F, Regnault B, Attia M, Baquero Salazar E, Chretien D, Conquet L, Jouvion G, Pipoli Da Fonseca J, Cokelaer T, Amara F, Relouzat F, Naninck T, Lemaitre J, Derreudre-Bosquet N, Pascal Q, Bonomi M, Bigot T, Munier S, Rey FA, Le Grand R, van der Werf S, Eloit M, SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19., EMBO Rep 2023 Apr; 24(4): e56055.
• 2023
  Prudencio CR, Gomes da Costa V, Rocha LB, Costa HHM, Orts DJB, da Silva Santos FR, Rahal P, Lino NAB, da Conceição PJP, Bittar C, Machado RRG, Durigon EL, Araujo JP, Polatto JM, da Silva MA, de Oliveira JA, Mitsunari T, Pereira LR, Andreata-Santos R, de Souza Ferreira LC, Luz D, Piazza RMF, Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests., Viruses 2023 Feb; 15(3): .
• 2023
  Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, Grzelak L, Prot M, Mougari S, Planchais C, Puech J, Saliba M, Sahraoui R, Fémy F, Morel N, Dufloo J, Sanjuán R, Mouquet H, André E, Hocqueloux L, Simon-Loriere E, Veyer D, Prazuck T, Péré H, Schwartz O, , Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies., Nat Commun 2023 Feb; 14(1): 824.
• 2023
  Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, Bonam SR, Bourgarit A, Dubost C, Bousquet A, Le Burel S, Mestiri R, Sene D, Galland J, Vasse M, Groh M, Le Marchand M, Vassord-Dang C, Gautier JF, Pham-Thi N, Verny C, Pitard B, Planchais C, Mouquet H, Paul R, Simon-Loriere E, Bayry J, Gilardin L, Sakuntabhai A,, Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants., iScience 2023 Feb; (): 106124.
• 2023
  Trémeaux P, Lemoine F, Mélard A, Gousset M, Boufassa F, Orr S, Monceaux V, Gascuel O, Lambotte O, Hocqueloux L, Saez-Cirion A, Rouzioux C, Avettand-Fenoel V, , In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control., Microbiol Spectr 2023 Feb; 11(1): e0326722.
• 2023
  Djaffardjy M, Marchment G, Sebe C, Blanchet R, Bellajhame K, Gaignard A, Lemoine F, Cohen-Boulakia S, , Developing and reusing bioinformatics data analysis pipelines using scientific workflow systems., Comput Struct Biotechnol J 2023 ; 21(): 2075-2085.
• 2022
  Baker JM, Shah MM, O'Hegarty M, Pomeroy M, Keiser P, Ren P, Weaver SC, Maknojia S, Machado RRG, Mitchell BM, McConnell A, Tate JE, Kirking HL, Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021., J Pediatric Infect Dis Soc 2022 Dec; 11(12): 550-556.
• 2022
  Bruel T, Stéfic K, Nguyen Y, Toniutti D, Staropoli I, Porrot F, Guivel-Benhassine F, Bolland WH, Planas D, Hadjadj J, Handala L, Planchais C, Prot M, Simon-Lorière E, André E, Baele G, Cuypers L, Mouthon L, Mouquet H, Buchrieser J, Sève A, Prazuck T, Maes P, Terrier B, Hocqueloux L, Schwartz O, , Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies., Cell Rep Med 2022 Nov; (): 100850.
• 2022
  Planas D, Staropoli I, Porot F, Guivel-Benhassine F, Handala L, Prot M, Bolland WH, Puech J, Péré H, Veyer D, Sève A, Simon-Lorière E, Bruel T, Prazuck T, Stefic K, Hocqueloux L, Schwartz O, , Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection., Med (N Y) 2022 Dec; 3(12): 838-847.e3.
• 2022
  Plante JA, Machado RRG, Mitchell BM, Shinde DP, Walker J, Scharton D, McConnell A, Saada N, Liu J, Khan B, Campos RK, Johnson BA, Menachery VD, Levine CB, Ren P, McLellan SLF, Plante KS, Weaver SC, Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients., Viruses 2022 Sep; 14(9): .
• 2022
  Liu Y, Liu J, Zou J, Kalveram B, Machado RRG, Ren P, Türeli S, Smith DJ, Weaver SC, Xie X, Shi PY, Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes., Signal Transduct Target Ther 2022 Aug; 7(1): 285.
• 2022
  Srinivasan V, Brognaro H, Prabhu PR, de Souza EE, Günther S, Reinke PYA, Lane TJ, Ginn H, Han H, Ewert W, Sprenger J, Koua FHM, Falke S, Werner N, Andaleeb H, Ullah N, Franca BA, Wang M, Barra ALC, Perbandt M, Schwinzer M, Schmidt C, Brings L, Lorenzen K, Schubert R, Machado RRG, Candido ED, Oliveira DBL, Durigon EL, Niebling S, Garcia AS, Yefanov O, Lieske J, Gelisio L, Domaracky M, Middendorf P, Groessler M, Trost F, Galchenkova M, Mashhour AR, Saouane S, Hakanpää J, Wolf M, Alai MG, Turk D, Pearson AR, Chapman HN, Hinrichs W, Wrenger C, Meents A, Betzel C, Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease., Commun Biol 2022 Aug; 5(1): 805.
• 2022
  Bruel T, Hadjadj J, Maes P, Planas D, Seve A, Staropoli I, Guivel-Benhassine F, Porrot F, Bolland WH, Nguyen Y, Casadevall M, Charre C, Péré H, Veyer D, Prot M, Baidaliuk A, Cuypers L, Planchais C, Mouquet H, Baele G, Mouthon L, Hocqueloux L, Simon-Loriere E, André E, Terrier B, Prazuck T, Schwartz O, Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies., Nat Med 2022 Jun; 28(6): 1297-1302.
• 2022
  Song ATW, Rocha V, Mendrone-Júnior A, Calado RT, De Santis GC, Benites BD, Costa-Lima C, Vargas T, Marques LS, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Avelino-Silva VI, Machado RRG, Durigon EL, Chevret S, Kallas EG, Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)., Lancet Reg Health Am 2022 Jun; 10(): 100216.
• 2022
  Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F, Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 May; 13(1): 2442.
• 2022
  Nielsen MC, Machado RRG, Mitchell BM, McConnell AJ, Saada NI, Weaver SC, Ren P, A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants., J Mol Diagn 2022 May; 24(5): 455-461.
• 2022
  Rensen E, Pietropaoli S, Mueller F, Weber C, Souquere S, Sommer S, Isnard P, Rabant M, Gibier JB, Terzi F, Simon-Loriere E, Rameix-Welti MA, Pierron G, Barba-Spaeth G, Zimmer C, Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH., Life Sci Alliance 2022 Apr; 5(4): .
• 2022
  Saunders N, Planas D, Bolland WH, Rodriguez C, Fourati S, Buchrieser J, Planchais C, Prot M, Staropoli I, Guivel-Benhassine F, Porrot F, Veyer D, Péré H, Robillard N, Saliba M, Baidaliuk A, Seve A, Hocqueloux L, Prazuck T, Rey FA, Mouquet H, Simon-Lorière E, Bruel T, Pawlotsky JM, Schwartz O, Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2., EBioMedicine 2022 Mar; 77(): 103934.
• 2022
  Zou J, Xia H, Xie X, Kurhade C, Machado RRG, Weaver SC, Ren P, Shi PY, Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection., Nat Commun 2022 Feb; 13(1): 852.
• 2022
  Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, Péré H, Veyer D, Puech J, Rodary J, Baele G, Dellicour S, Raymenants J, Gorissen S, Geenen C, Vanmechelen B, Wawina-Bokalanga T, Martí-Carreras J, Cuypers L, Sève A, Hocqueloux L, Prazuck T, Rey FA, Simon-Loriere E, Bruel T, Mouquet H, André E, Schwartz O, Considerable escape of SARS-CoV-2 Omicron to antibody neutralization., Nature 2022 Feb; 602(7898): 671-675.
• 2022
  Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP, Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial., Eur Respir J 2022 Feb; 59(2): .
• 2022
  Oliveira JR, Ruiz CMR, Machado RRG, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, de Medeiros GX, Júnior RCVS, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Nakaya HI, Cunha-Neto E, Gadermaier G, Kalil J, Coelho V, Santos KS, Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape., Front Immunol 2022 ; 13(): 1010105.
• 2022
  Andreata-Santos R, Machado RRG, Alves RPDS, Sales NS, Soares CP, Rodrigues KB, Silva MO, Favaro MTP, Rodrigues-Jesus MJ, Yamamoto MM, de Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LCS, Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil., Front Cell Infect Microbiol 2022 ; 12(): 787411.
• 2022
  Silva EKVB, Bomfim CG, Barbosa AP, Noda P, Noronha IL, Fernandes BHV, Machado RRG, Durigon EL, Catanozi S, Rodrigues LG, Pieroni F, Lima SG, Teodoro WR, Queiroz ZAJ, Silveira LKR, Charlie-Silva I, Capelozzi VL, Guzzo CR, Fanelli C, Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats., PLoS One 2022 ; 17(5): e0268434.
• 2021
  Bertanha M, Rodrigues LDS, Mellucci Filho PL, Moroz A, Pardini MIMC, Sobreira ML, Durigon EL, Machado RRG, Grotto RMT, Lima MA, Nader HB, Moraes ML, Barbosa AN, Medolago NB, Cardoso FF, Magro AJ, Carvalho CRG, Moraes LN, Alvarado RC, Nunes HC, Campos GC, Grillo VTRDS, Sertorio ND, Fortaleza CMCB, Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial., Medicine (Baltimore) 2021 Dec; 100(51): e28288.
• 2021
  Inizan C, Minier M, Prot M, O'Connor O, Forfait C, Laumond S, Marois I, Biron A, Gourinat AC, Goujart MA, Descloux E, Sakuntabhai A, Tarantola A, Simon-Lorière E, Dupont-Rouzeyrol M, , Viral evolution sustains a dengue outbreak of enhanced severity., Emerg Microbes Infect 2021 Dec; 10(1): 536-544.
• 2021
  Frantz PN, Barinov A, Ruffié C, Combredet C, Najburg V, de Melo GD, Larrous F, Kergoat L, Teeravechyan S, Jongkaewwattana A, Billon-Denis E, Tournier JN, Prot M, Levillayer L, Conquet L, Montagutelli X, Tichit M, Hardy D, Fernandes P, Strick-Marchand H, Di Santo J, Simon-Lorière E, Bourhy H, Tangy F, A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters., Nat Commun 2021 Nov; 12(1): 6277.
• 2021
  Wendel S, Fachini R, Fontão-Wendel RCL, Mello R, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL, Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?, Transfusion 2021 Dec; 61(12): 3455-3467.
• 2021
  Delaune D, Hul V, Karlsson EA, Hassanin A, Ou TP, Baidaliuk A, Gámbaro F, Prot M, Tu VT, Chea S, Keatts L, Mazet J, Johnson CK, Buchy P, Dussart P, Goldstein T, Simon-Lorière E, Duong V, , A novel SARS-CoV-2 related coronavirus in bats from Cambodia., Nat Commun 2021 11; 12(1): 6563.
• 2021
  Machado RRG, Glaser T, Araujo DB, Petiz LL, Oliveira DBL, Durigon GS, Leal AL, Pinho JRR, Ferreira LCS, Ulrich H, Durigon EL, Guzzo CR, Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells., ACS Pharmacol Transl Sci 2021 Oct; 4(5): 1514-1527.
• 2021
  da Silva Santos PS, da Fonseca Orcina B, Machado RRG, Vilhena FV, da Costa Alves LM, Zangrando MSR, de Oliveira RC, Soares MQS, Simão ANC, Pietro ECIN, Kuroda JPG, de Almeida Benjamim IA, Araujo DB, Toma SH, Flor L, Araki K, Durigon EL, Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial., Sci Rep 2021 Oct; 11(1): 19937.
• 2021
  Venceslau-Carvalho AA, Teixeira de Pinho Favaro M, Ramos Pereira L, Rodrigues-Jesus MJ, Santos Pereira S, Andreata-Santos R, Dos Santos Alves RP, Castro-Amarante MF, Bitencourt Rodrigues K, Ramos da Silva J, Rahal Guaragna Machado R, Dos Passos Cunha M, Marinho de Andrade Zanotto P, Luzetti Fotoran W, Wunderlich G, Durigon EL, de Souza Ferreira LC, Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies., Nanomedicine 2021 Oct; 37(): 102445.
• 2021
  Jaworski E, Langsjoen RM, Mitchell B, Judy B, Newman P, Plante JA, Plante KS, Miller AL, Zhou Y, Swetnam D, Sotcheff S, Morris V, Saada N, Machado RR, McConnell A, Widen SG, Thompson J, Dong J, Ren P, Pyles RB, Ksiazek TG, Menachery VD, Weaver SC, Routh AL, Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants., Elife 2021 Sep; 10(): .
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J, Prot M, Gallais F, Gantner P, Velay A, Le Guen J, Kassis-Chikhani N, Edriss D, Belec L, Seve A, Courtellemont L, Péré H, Hocqueloux L, Fafi-Kremer S, Prazuck T, Mouquet H, Bruel T, Simon-Lorière E, Rey FA, Schwartz O, , Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization., Nature 2021 08; 596(7871): 276-280.
• 2021
  Firpo MR, Mastrodomenico V, Hawkins GM, Prot M, Levillayer L, Gallagher T, Simon-Loriere E, Mounce BC, , Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry., ACS Infect Dis 2021 06; 7(6): 1423-1432.
• 2021
  de Laval F, Grosset-Janin A, Delon F, Allonneau A, Tong C, Letois F, Couderc A, Sanchez MA, Destanque C, Biot F, Raynaud F, Bigaillon C, Ferraris O, Simon-Loriere E, Enouf V, Andriamanantena D, de Santi VP, Javelle E, Mérens A, Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them., BMC Infect Dis 2021 May; 21(1): 457.
• 2021
  Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, Planchais C, Buchrieser J, Rajah MM, Bishop E, Albert M, Donati F, Prot M, Behillil S, Enouf V, Maquart M, Smati-Lafarge M, Varon E, Schortgen F, Yahyaoui L, Gonzalez M, De Sèze J, Péré H, Veyer D, Sève A, Simon-Lorière E, Fafi-Kremer S, Stefic K, Mouquet H, Hocqueloux L, van der Werf S, Prazuck T, Schwartz O, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies., Nat Med 2021 May; 27(5): 917-924.
• 2021
  Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckier F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachia A, Friedlander G, Chrétien F, Simon-Loriere E, Gaillard R, Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine., Int J Antimicrob Agents 2021 Mar; 57(3): 106274.
• 2021
  Aubry F, Jacobs S, Darmuzey M, Lequime S, Delang L, Fontaine A, Jupatanakul N, Miot EF, Dabo S, Manet C, Montagutelli X, Baidaliuk A, Gámbaro F, Simon-Lorière E, Gilsoul M, Romero-Vivas CM, Cao-Lormeau VM, Jarman RG, Diagne CT, Faye O, Faye O, Sall AA, Neyts J, Nguyen L, Kaptein SJF, Lambrechts L, , Recent African strains of Zika virus display higher transmissibility and fetal pathogenicity than Asian strains., Nat Commun 2021 02; 12(1): 916.
• 2020
  Aubry F, Dabo S, Manet C, Filipović I, Rose NH, Miot EF, Martynow D, Baidaliuk A, Merkling SH, Dickson LB, Crist AB, Anyango VO, Romero-Vivas CM, Vega-Rúa A, Dusfour I, Jiolle D, Paupy C, Mayanja MN, Lutwama JJ, Kohl A, Duong V, Ponlawat A, Sylla M, Akorli J, Otoo S, Lutomiah J, Sang R, Mutebi JP, Cao-Lormeau VM, Jarman RG, Diagne CT, Faye O, Faye O, Sall AA, McBride CS, Montagutelli X, Rašić G, Lambrechts L, , Enhanced Zika virus susceptibility of globally invasive Aedes aegypti populations., Science 2020 11; 370(6519): 991-996.
• 2020
  Inizan C, O'Connor O, Worwor G, Cabemaiwai T, Grignon JC, Girault D, Minier M, Prot M, Ballan V, Pakoa GJ, Grangeon JP, Guyant P, Lepers C, Faktaufon D, Sahukhan A, Merilles OE, Gourinat AC, Simon-Lorière E, Dupont-Rouzeyrol M, , Molecular Characterization of Dengue Type 2 Outbreak in Pacific Islands Countries and Territories, 2017-2020., Viruses 2020 09; 12(10): .
• 2020
  Suzuki Y, Baidaliuk A, Miesen P, Frangeul L, Crist AB, Merkling SH, Fontaine A, Lequime S, Moltini-Conclois I, Blanc H, van Rij RP, Lambrechts L, Saleh MC, , Non-retroviral Endogenous Viral Element Limits Cognate Virus Replication in Aedes aegypti Ovaries., Curr Biol 2020 09; 30(18): 3495-3506.e6.
• 2020
  Ku MW, Anna F, Souque P, Petres S, Prot M, Simon-Loriere E, Charneau P, Bourgine M, , A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus., Mol Ther 2020 08; 28(8): 1772-1782.
• 2020
  Pierre Garneret, Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe Gonzalez Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie Van der Werf, Jessica Vanhomwegen, Patrick Jean Tabeling, Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification., medRxiv 2020.08.01.20166538.
• 2020
  Gámbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, Vanpeene M, Bizard M, Brisebarre A, Barbet M, Derrar F, van der Werf S, Enouf V, Simon-Loriere E, , Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
• 2020
  Faye O, de Lourdes Monteiro M, Vrancken B, Prot M, Lequime S, Diarra M, Ndiaye O, Valdez T, Tavarez S, Ramos J, da Veiga Leal S, Pires C, Moreira A, Tavares MF, Fernandes L, Barreto JN, do Céu Teixeira M, de Lima Mendonça MDL, Gomes CCDSL, Castellon MS, Ma L, Lemoine F, Gámbaro-Roglia F, Delaune D, Fall G, Fall IS, Diop M, Sakuntabhai A, Loucoubar C, Lemey P, Holmes EC, Faye O, Sall AA, Simon-Loriere E, , Genomic Epidemiology of 2015-2016 Zika Virus Outbreak in Cape Verde., Emerg Infect Dis 2020 06; 26(6): 1084-1090.
• 2020
  Manet C, Simon-Lorière E, Jouvion G, Hardy D, Prot M, Conquet L, Flamand M, Panthier JJ, Sakuntabhai A, Montagutelli X, , Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b., J Virol 2020 01; 94(3): .
• 2020
  Baidaliuk A, Lequime S, Moltini-Conclois I, Dabo S, Dickson LB, Prot M, Duong V, Dussart P, Boyer S, Shi C, Matthijnssens J, Guglielmini J, Gloria-Soria A, Simon-Lorière E, Lambrechts L, , Novel genome sequences of cell-fusing agent virus allow comparison of virus phylogeny with the genetic structure of Aedes aegypti populations., Virus Evol 2020 Jan; 6(1): veaa018.
• 2019
  Baidaliuk A, Miot EF, Lequime S, Moltini-Conclois I, Delaigue F, Dabo S, Dickson LB, Aubry F, Merkling SH, Cao-Lormeau VM, Lambrechts L, , Cell-Fusing Agent Virus Reduces Arbovirus Dissemination in Aedes aegypti Mosquitoes In Vivo., J Virol 2019 09; 93(18): .
• 2019
  Roth C, Cantaert T, Colas C, Prot M, Casadémont I, Levillayer L, Thalmensi J, Langlade-Demoyen P, Gerke C, Bahl K, Ciaramella G, Simon-Loriere E, Sakuntabhai A, A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice, Front. Immunol. 2019 Jun;10 (1424).
• 2018
  De Moraes CG, Pettito M, Yepez JB, Sakuntabhai A, Simon-Loriere E, Zaidi MB, Prot M, Ruffie C, Kim SS, Allikmets R, Terwilliger JD, Lee JH, Maestre GE, , Corrigendum: Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients., JMM Case Rep 2018 08; 5(8): e005161.
• 2018
  Zaidi MB, De Moraes CG, Petitto M, Yepez JB, Sakuntabhai A, Simon-Loriere E, Prot M, Ruffie C, Kim SS, Allikmets R, Terwilliger JD, Lee JH, Maestre GE, , Non-congenital severe ocular complications of Zika virus infection., JMM Case Rep 2018 Jun; 5(6): e005152.
• 2018
  Nikolayeva I, Bost P, Casademont I, Duong V, Koeth F, Prot M, Czerwinska U, Ly S, Bleakley K, Cantaert T, Dussart P, Buchy P, Simon-Lorière E, Sakuntabhai A, Schwikowski B, , A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival., J Infect Dis 2018 May; 217(11): 1690-1698.
• 2018
  De Moraes CG, Pettito M, Yepez JB, Sakuntabhai A, Simon-Loriere E, Zaidi MB, Prot M, Ruffie C, Kim SS, Allikmets R, Terwilliger JD, Lee JH, Maestre GE, , Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients., JMM Case Rep 2018 05; 5(5): e005145.
• 2018
  Fernandez-Garcia MD, Volle R, Joffret ML, Sadeuh-Mba SA, Gouandjika-Vasilache I, Kebe O, Wiley MR, Majumdar M, Simon-Loriere E, Sakuntabhai A, Palacios G, Martin J, Delpeyroux F, Ndiaye K, Bessaud M, , Genetic Characterization of Enterovirus A71 Circulating in Africa., Emerging Infect. Dis. 2018 04; 24(4): 754-757.
• 2017
  Simon-Lorière E, Duong V, Tawfik A, Ung S, Ly S, Casadémont I, Prot M, Courtejoie N, Bleakley K, Buchy P, Tarantola A, Dussart P, Cantaert T, Sakuntabhai A, , Increased adaptive immune responses and proper feedback regulation protect against clinical dengue., Sci Transl Med 2017 Aug; 9(405): .
• 2017
  Simon-Loriere E, Faye O, Prot M, Casademont I, Fall G, Fernandez-Garcia MD, Diagne MM, Kipela JM, Fall IS, Holmes EC, Sakuntabhai A, Sall AA, , Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa., N Engl J Med 2017 04; 376(15): 1483-1485.
• 2017
  Ly S, Navaroli DM, Didiot MC, Cardia J, Pandarinathan L, Alterman JF, Fogarty K, Standley C, Lifshitz LM, Bellve KD, Prot M, Echeverria D, Corvera S, Khvorova A, , Visualization of self-delivering hydrophobically modified siRNA cellular internalization., Nucleic Acids Res 2017 01; 45(1): 15-25.
• 2016
  Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel MP, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M, , Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses., J Virol 2016 Nov; 90(21): 9683-9692.
• 2016
  Mounce BC, Poirier EZ, Passoni G, Simon-Loriere E, Cesaro T, Prot M, Stapleford KA, Moratorio G, Sakuntabhai A, Levraud JP, Vignuzzi M, , Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine Depletion Restrict Zika and Chikungunya Viruses., Cell Host Microbe 2016 Aug; 20(2): 167-77.
• 2016
  Calderon D, Prot M, You S, Marquet C, Bellamy V, Bruneval P, Valette F, de Almeida P, Wu JC, Pucéat M, Menasché P, Chatenoud L, , Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction., Am J Transplant 2016 Feb; 16(2): 454-67.
• 2011
  Tesz GJ, Aouadi M, Prot M, Nicoloro SM, Boutet E, Amano SU, Goller A, Wang M, Guo CA, Salomon WE, Virbasius JV, Baum RA, O'Connor MJ, Soto E, Ostroff GR, Czech MP, , Glucan particles for selective delivery of siRNA to phagocytic cells in mice., Biochem J 2011 Jun; 436(2): 351-62.
• 2011
  Boutet E, Ranjit S, Gandhi P, Prot M, Tamori Y, Chawla A, Greenberg AS, Puri V, Czech MP, , Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes., J Lipid Res 2011 Feb; 52(2): 221-36.
• 2010
  Boccara F, Auclair M, Cohen A, Lefèvre C, Prot M, Bastard JP, Capeau J, Caron-Debarle M, , HIV protease inhibitors activate the adipocyte renin angiotensin system., Antivir Ther 2010 ; 15(3): 363-75.
• 2009
  Boutet E, El Mourabit H, Prot M, Nemani M, Khallouf E, Colard O, Maurice M, Durand-Schneider AM, Chrétien Y, Grès S, Wolf C, Saulnier-Blache JS, Capeau J, Magré J, , Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy., Biochimie 2009 Jun; 91(6): 796-803.
• 2007
  Lagathu C, Eustace B, Prot M, Frantz D, Gu Y, Bastard JP, Maachi M, Azoulay S, Briggs M, Caron M, Capeau J, , Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages., Antivir Ther 2007 ; 12(4): 489-500.
• 2006
  Prot M, Heripret L, Cardot-Leccia N, Perrin C, Aouadi M, Lavrut T, Garraffo R, Dellamonica P, Durant J, Le Marchand-Brustel Y, Binétruy B, , Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice., Antimicrob Agents Chemother 2006 Dec; 50(12): 3998-4004.
• 2006
  Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binétruy B, Bost F, , Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages., Diabetes 2006 Feb; 55(2): 281-9.
• 2005
  Caron L, Bost F, Prot M, Hofman P, Binétruy B, , A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells., Oncogene 2005 Sep; 24(41): 6281-91.
• 2005
  Caron L, Prot M, Rouleau M, Rolando M, Bost F, Binétruy B, , The Lac repressor provides a reversible gene expression system in undifferentiated and differentiated embryonic stem cell., Cell Mol Life Sci 2005 Jul; 62(14): 1605-12.
• 2005
  Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pagès G, Pouysségur J, Le Marchand-Brustel Y, Binétruy B, , The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis., Diabetes 2005 Feb; 54(2): 402-11.